NextCure, Inc. (NXTC) stock
NXTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.40+0.17 (+2.73%)
Close on Nov 13, 2026Market cap $29.30MP/E –Yield 0.00%
NextCure enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
NextCure's enterprise value was $9.07M on Nov 11, 2026, against $30.38M a year earlier. Over the last 5 years it ranged from -$14.69M to $129.02M, with a median of $16.22M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $9.07M | -70.4% |
| 2025 | Dec 31, 2025 | $30.65M | – |
| 2024 | Dec 31, 2024 | -$6.13M | -150.2% |
| 2023 | Dec 29, 2023 | $12.22M | +52.0% |
| 2022 | Dec 30, 2022 | $8.04M | -93.8% |
| 2021 | Dec 31, 2021 | $129.02M | +1318.5% |
| 2020 | Dec 31, 2020 | $9.10M | -99.2% |
| 2019 | Dec 31, 2019 | $1.10B | – |
See a number that looks wrong?